• Oct 07, 2013 | Webcast

    Up and Coming Treatments for Bone Disease

    Michael Econs, MD; John Eisman, MBBS, PhD; Michael Whyte, MD; Seiji Fukumoto, MD, PhD; Bente Langdahl, MD, DMSc
    Investigation of Metabolic Bone Diseases, Rare Bone Diseases

    Michael Econs, M.D.
    Indiana University School of Medicine, USA

    John Eisman, MBBS, Ph.D.
    Garvan Institute of Medical Research, Australia

    Hypophosphatasia: Bone-Targeted Enzyme-Replacement Therapy
    Michael Whyte, M.D.
    Shriners Hospital for Children-Saint Louis, USA

    Prospects for FGF-23 Antibody Therapy
    Seiji Fukumoto, M.D., Ph.D.
    University of Tokyo Hospital, Japan

    Osteoporosis, Cathepsin K Enzyme Inhibition
    Bente Langdahl, M.D., DMSc
    Aarhus University Hospital, Denmark

    Supported by educational grants from Lilly USA, LLC and Merck & Co., Inc.

    Length: 75 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details